Chip stocks continue to surge. Here's how to buy into the trend for less

Marvell Technology (MRVL) is up more than 130% year-to-date and over 220% in the past 52 weeks, but the article argues the stock is too extended to chase into Tuesday's earnings. The options market is pricing an implied ~13.5% post-earnings move, while the author highlights a forward P/E near 45x, a 10-year high, and elevated RSI/readings as signs of stretched positioning. The recommended trade is to sell the June 5 weekly 162.5 put for $3.60, targeting a >2.2% standstill yield and betting MRVL holds up or only pulls back modestly.

Analysis

MRVL is a classic case where the fundamental story and the trade are no longer the same thing. The market is effectively paying today for a clean execution path on AI custom silicon, but the setup is now more sensitive to any evidence of deceleration in hyperscaler order cadence, gross margin mix, or guide conservatism. At this stage, the stock is less about absolute growth and more about the delta versus an already very high bar; that makes the next move asymmetrical around guidance quality rather than headline revenue alone.

The second-order effect is that elevated expectations can pull forward multiple compression even if the quarter is fine. If management sounds even slightly cautious on near-term ramps, the stock can derate faster than fundamentals worsen because positioning is crowded and options pricing implies a meaningful post-print move. Conversely, a modest beat may still fail to produce follow-through if the market decides the AI infrastructure trade needs a new catalyst rather than just confirmation.

The most interesting part of the setup is not direction, but timing. Over the next few days, implied volatility is rich enough that selling downside into a level where the business case is still intact offers better risk/reward than buying upside into peak anticipation. Over the next few months, the real risk is not demand disappearance; it's digestion—capex phasing, supply normalization, and investors rotating to the next under-owned AI beneficiary once MRVL stops surprising.

Consensus is missing that a strong story can become a poor entry point when the stock has already discounted several quarters of perfection. The market is treating MRVL like a high-conviction structural winner, but the near-term tape is trading like a momentum name with crowded ownership and elevated event risk. That combination usually favors patient premium collection or pullback entries over directional chasing.

Key Decisions for Investors

• Sell MRVL downside into earnings via the June 5th weekly puts or a put spread, targeting strikes 10-15% below spot; attractive if the goal is 2-3% premium capture over ~1-2 weeks with defined assignment risk.
• If long MRVL for strategic exposure, wait for post-earnings compression or a failed breakout to add; use any 5-8% pullback as a higher-quality entry than chasing strength into a crowded print.
• For more convex exposure, consider a short-dated call spread instead of stock ahead of earnings; this preserves upside participation while capping theta bleed in an already extended name.
• Relative value: pair long a lower-multiple AI infrastructure beneficiary against short MRVL if the print is good but the guide is merely solid; this isolates multiple risk and reduces beta exposure to the broader semicap complex.
• If MRVL gaps up strongly and holds, fade the move only after the initial post-earnings vol crush; the better risk/reward is to wait for intraday exhaustion rather than shorting the headline reaction.